Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-05Clinical Trial Update: Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer [NA]
A clinical trial evaluating daily adaptive radiation therapy for Stage III non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients [Phase 2]
This is an update on a Phase 2 study evaluating the clinical utility of liquid biopsy in patients with ALK-positive non-small cell lung canc…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Insomnia in Patients With Metastatic Lung Cancer
Clinical trial investigating insomnia in patients with metastatic non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: MPDL3280A With Chemoradiation for Lung Cancer [Phase 2]
Phase 2 trial investigating atezolizumab (MPDL3280A) with chemoradiation for lung cancer (non-small cell lung cancer); current status is act…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung [Phase 2]
A Phase 2 randomized trial evaluating stereotactic body radiation therapy (SBRT) in patients with oligoprogressive metastatic breast and lun…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial investigating single-fraction stereotactic body radiation therapy after surgery for non-small cell lung cancer; the s…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors [Phase 1]
Clinical trial update for RMC-5127 in KRAS G12V-mutant advanced solid tumors shows Phase 1 recruitment ongoing across non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease [Phase 1]
This clinical trial update describes a Phase 1 study evaluating photodynamic therapy to amplify the response to immunotherapy in patients wi…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients [Phase 2]
A Phase 2 study evaluating the combination of osimertinib and aspirin in patients with EGFR-mutant non-small cell lung cancer (stage IV) has…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 2, Phase 3]
A completed phase 2/3 trial comparing tiragolumab plus atezolizumab with pemetrexed and platinum chemotherapy versus pembrolizumab plus peme…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study
Qualitative study assessing cancer-related fatigue during maintenance immunotherapy for non-small cell lung cancer in a clinical trial setti…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer [Phase 3]
A Phase III clinical trial is evaluating HB0025 plus chemotherapy versus tislelizumab plus chemotherapy as first-line therapy for advanced n…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study of EP0031 in Patients With Advanced RET-altered Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for EP0031 in patients with advanced RET-altered malignancies, including non-small cell lung cancer, which…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial sponsored by GlaxoSmithKline evaluating PD-L1 response using extracellular vesicles, patient-derived organo…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Lung Cancer Screening in Population Who Had Never Smoked [NA]
A clinical trial update describing a study on lung cancer screening in people who have never smoked; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study [NA]
The PERCC study is currently recruiting participants with non-small cell lung cancer (stage II and stage III) to evaluate a precision exerci…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy [Phase 3]
Phase 3 study evaluating tiragolumab plus atezolizumab versus placebo plus atezolizumab in completely resected non-small cell lung cancer af…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial results compare lazertinib with subcutaneous amivantamab to intravenous amivantamab in patients with EGFR-mutated advanced or …
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing lazertinib with subcutaneous amivantamab versus intravenous amivantamab in EGFR-mutated advanced or metastatic non…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface [Phase 1]
A Phase 1 study evaluating different doses of BI-765049 alone and in combination with Ezabenlimab in patients with advanced solid tumors exp…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation [Phase 2]
A Phase 2 study of PRT3789 in combination with pembrolizumab for SMARCA4-mutant advanced or metastatic solid tumors was terminated. The stud…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: 3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a 3D virtual reality planning approach combined with indocyanine green fluorescence mapping to guide t…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation [Phase 1]
A Phase 1 study of PRT7732, an oral SMARCA2 degrader, in patients with SMARCA4-mutant advanced or metastatic solid tumors has been terminate…
-
CLINICAL_TRIALS other · 2026-02-02Clinical Trial Update: A Phase Ⅲ Clinical Study of SYS6010 in Combination With Osimertinib in Patients With Locally Advanced or Metastatic NSCLC [Phase 3]
A Phase 3 clinical study of SYS6010 in combination with Osimertinib for locally advanced or metastatic non-small cell lung cancer is not yet…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 [Phase 1]
Phase 1 study GO44010 evaluates RO7496353 in combination with a checkpoint inhibitor (with or without standard chemotherapy) in locally adva…